Cargando…

Immunomodulatory Nanosystems

Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiangru, Xu, Weiguo, Li, Zhongmin, Song, Wantong, Ding, Jianxun, Chen, Xuesi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724480/
https://www.ncbi.nlm.nih.gov/pubmed/31508270
http://dx.doi.org/10.1002/advs.201900101
_version_ 1783449003207163904
author Feng, Xiangru
Xu, Weiguo
Li, Zhongmin
Song, Wantong
Ding, Jianxun
Chen, Xuesi
author_facet Feng, Xiangru
Xu, Weiguo
Li, Zhongmin
Song, Wantong
Ding, Jianxun
Chen, Xuesi
author_sort Feng, Xiangru
collection PubMed
description Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off‐target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed.
format Online
Article
Text
id pubmed-6724480
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67244802019-09-10 Immunomodulatory Nanosystems Feng, Xiangru Xu, Weiguo Li, Zhongmin Song, Wantong Ding, Jianxun Chen, Xuesi Adv Sci (Weinh) Reviews Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off‐target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed. John Wiley and Sons Inc. 2019-06-21 /pmc/articles/PMC6724480/ /pubmed/31508270 http://dx.doi.org/10.1002/advs.201900101 Text en © 2019 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Feng, Xiangru
Xu, Weiguo
Li, Zhongmin
Song, Wantong
Ding, Jianxun
Chen, Xuesi
Immunomodulatory Nanosystems
title Immunomodulatory Nanosystems
title_full Immunomodulatory Nanosystems
title_fullStr Immunomodulatory Nanosystems
title_full_unstemmed Immunomodulatory Nanosystems
title_short Immunomodulatory Nanosystems
title_sort immunomodulatory nanosystems
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724480/
https://www.ncbi.nlm.nih.gov/pubmed/31508270
http://dx.doi.org/10.1002/advs.201900101
work_keys_str_mv AT fengxiangru immunomodulatorynanosystems
AT xuweiguo immunomodulatorynanosystems
AT lizhongmin immunomodulatorynanosystems
AT songwantong immunomodulatorynanosystems
AT dingjianxun immunomodulatorynanosystems
AT chenxuesi immunomodulatorynanosystems